![](https://www.discoverx.com/content/uploads/2023/05/COVID-19_Small-Card-Image-310x174.jpg)
Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays
Read MoreShowing 1–12 of 13 results
Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays
Read MoreEnsure long-term assay reproducibility with the production of bioassay cells — critical reagents for cell banks. Learn about custom scale-up…
Read MoreAccelerate cancer immunotherapy drug development with easy-to-use, functional cell-based assays targeted at checkpoint receptors
Read MoreSimple, non-radioactive, & dye-free cytotoxicity assays to specifically measure target cell death
Read MoreUniversal G-protein independent cell-based assays to quantify GPCR activation based on the recruitment of β-arrestin
Read MoreAssays to interrogate the MOA of GLP-1, GIP, and GCG receptors targeting therapeutics to accelerate obesity and type-2 diabetes drug…
Read MoreAccelerate cancer immunotherapeutic discovery & development with cell-based, clinically relevant assays
Read MoreOver 500 high-quality & purified recombinant kinases, phosphatases, & epigenetic & ubiquitin proteins
Read MoreInterrogate a variety of popular target-specific signaling pathways with cell-based assays
Read MoreRapid cell-based assays for detecting protein turnover induced by targeted degrader molecules, such as PROTACs
Read MoreScreening cell-based translocation assays for analyzing the movement of proteins to multiple membrane compartments within the cell
Read More